Treating High-risk Neuroblastoma - Where are we now?

Dr Daniel Morgenstern welcomes participants and leads into an introductory talk on neuroblastoma. Topics include information on what neuroblastoma is, where it begins, as well as an overview of standard therapy regimens in Europe and North America, and the current direction of research.
This recorded presentation is from the 2022 symposium.